Stenotrophomonas maltophila bacteraemia in a chronic renal failure patient
Keywords:
Stenotrophomonas maltophila, bacteremia
Abstract
The spectrum of infection by Stenotrophomonas maltophila includes bacteraemia, catheter-related
infection, pneumonia, complicated biliary and urinary tract infection, and skin and skin-structure infection.
We report a case of Stenotrophomonas maltophila bacteraemia in a case of a chronic renal failure
patient who was receiving dialysis via a central venous catheter.
References
1. Amar Safdar and Kenneth V. Rolston, Stenotrophomonas maltophila: Changing Spectrum of a Serious Bacterial Pathogen in Patients with Cancer. Clinical Infectious Diseases.
2007 ; 45:1602-9.
2. Morrison AJ, Hoffman KF, Weizel RP Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophila in a university hospital. J Clin Microbiol.1986;24:52-5.
3. Trouillet JL, Chastre J, Vuagnat A, et al Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157:531-9.
4. Hanes SD, Demirkan K, Tolley E, et al Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophila in critically ill trauma patients. Clin Infect Dis. 2002;35:228-35.)
5. Gnanasekaran I., Bajaj R. Stenotrophomonas maltophilia bacteremia in end stage renal disease patients receiving maintainence hemodialysis. Dialysis & Transplantation 2009; 38:30-32.
6. Tzanetou K., Triantaphilis G., Tsousos D. et al. Stenotrophomonas maltophilia peritonitis in CAPD patients; susceptibility to antibiotics & treatment outcome. A report of five cases. Perit Dial Int. 2004; 24:401- 4.
7. Matthew E. Falagas*, Politimi-Eleni Valkimadi, Yu-Tsung Huang Dimitrios K. Matthaiou1 Po-RenHsueh. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review J of
Antimicrobial Chemotherapy. 2008; 62:889-94
8. Villarino MF, Stevens LE, Schable B, et al Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. Infect Control Hosp Epidemiol 1992;13:201-6.
2007 ; 45:1602-9.
2. Morrison AJ, Hoffman KF, Weizel RP Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophila in a university hospital. J Clin Microbiol.1986;24:52-5.
3. Trouillet JL, Chastre J, Vuagnat A, et al Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157:531-9.
4. Hanes SD, Demirkan K, Tolley E, et al Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophila in critically ill trauma patients. Clin Infect Dis. 2002;35:228-35.)
5. Gnanasekaran I., Bajaj R. Stenotrophomonas maltophilia bacteremia in end stage renal disease patients receiving maintainence hemodialysis. Dialysis & Transplantation 2009; 38:30-32.
6. Tzanetou K., Triantaphilis G., Tsousos D. et al. Stenotrophomonas maltophilia peritonitis in CAPD patients; susceptibility to antibiotics & treatment outcome. A report of five cases. Perit Dial Int. 2004; 24:401- 4.
7. Matthew E. Falagas*, Politimi-Eleni Valkimadi, Yu-Tsung Huang Dimitrios K. Matthaiou1 Po-RenHsueh. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review J of
Antimicrobial Chemotherapy. 2008; 62:889-94
8. Villarino MF, Stevens LE, Schable B, et al Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. Infect Control Hosp Epidemiol 1992;13:201-6.
Published
2019-11-28
How to Cite
Badhuli Samal, Baradkar V, Dash L, Kulkarni K, Shastri J. (2019). Stenotrophomonas maltophila bacteraemia in a chronic renal failure patient. The Indian Practitioner, 67(3), 173-175. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/887
Section
Case Reports
